Verition Fund Management LLC Biotechnology

Verition Fund Management LLC

$19.9 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RYTM Rhythm Pharmaceuticals, Inc.	$4.89B	$234,000 0.0% of portfolio	4,424	Q1 2025 Reduced 44.95%
XERS Xeris Biopharma Holdings, Inc.	$696M	$226,000 0.0% of portfolio	41,290	Q1 2025 Reduced 51.54%
CGEM Cullinan Oncology, Inc.	$370M	$220,000 0.0% of portfolio	29,175	Q1 2025 New
DAWN Day One Biopharmaceuticals, Inc.	$483M	$218,000 0.0% of portfolio	27,546	Q1 2025 Reduced 19.33%
ALDX Aldeyra Therapeutics, Inc.	$313M	$215,000 0.0% of portfolio	37,505	Q1 2025 New
SAVA Cassava Sciences Inc	$103M	$202,000 0.0% of portfolio	135,166	Q1 2025 Reduced 8.01%
AKBA Akebia Therapeutics, Inc.	$708M	$200,000 0.0% of portfolio	104,334	Q1 2025 New
ZNTL Zentalis Pharmaceuticals, Inc.	$81.5M	$194,000 0.0% of portfolio	122,282	Q1 2025 Reduced 89.95%
FULC Fulcrum Therapeutics, Inc.	$367M	$188,000 0.0% of portfolio	65,388	Q1 2025 Reduced 2.47%
DNLI Denali Therapeutics Inc.	$1.86B	$186,000 0.0% of portfolio	13,729	Q1 2025 Reduced 39.25%
ARVN Arvinas, Inc.	$403M	$178,000 0.0% of portfolio	25,357	Q1 2025 Reduced 58.11%
HLVX Hille Vax, Inc.	$69.9M	$169,000 0.0% of portfolio	116,755	Q1 2025 Reduced 30.43%
GERN Geron Corp	$484M	$162,000 0.0% of portfolio	102,064	Q1 2025 Added 134.47%
IOVA Iovance Biotherapeutics, Inc.	$494M	$153,000 0.0% of portfolio	46,151	Q1 2025 Added 30.4%
CDXC Chroma Dex Corp.	$420M	$140,000 0.0% of portfolio	20,320	Q1 2025 Reduced 67.83%
AVTE Aerovate Therapeutics, Inc.	$65.5M	$139,000 0.0% of portfolio	55,520	Q1 2025 Reduced 41.33%
MGNX Macrogenics Inc	$94.6M	$137,000 0.0% of portfolio	108,058	Q1 2025 New
IGMS Igm Biosciences, Inc.	$36.8M	$136,000 0.0% of portfolio	119,068	Q1 2025 New
THRD Third Harmonic Bio, Inc.	$219M	$136,000 0.0% of portfolio	39,390	Q1 2025 Added 250.44%
DYN Dyne Therapeutics, Inc.	$477M	$133,000 0.0% of portfolio	12,742	Q1 2025 Reduced 43.87%
ETON Eton Pharmaceuticals, Inc.	$360M	$132,000 0.0% of portfolio	10,189	Q1 2025 New
TBPH Theravance Biopharma, Inc.	$750M	$130,000 0.0% of portfolio	14,647	Q1 2025 New
FDMT 4 D Molecular Therapeutics, Inc.	$146M	$119,000 0.0% of portfolio	36,909	Q1 2025 Reduced 52.57%
ELEV Elevation Oncology, Inc.	$8.85M	$113,000 0.0% of portfolio	438,195	Q1 2025 New
RGNX Regenxbio Inc.	$370M	$111,000 0.0% of portfolio	15,579	Q1 2025 Reduced 39.78%
KMPH Kempharm, Inc	$170M	$111,000 0.0% of portfolio	22,520	Q1 2025 New
HUMA Humacyte, Inc.	$237M	$103,000 0.0% of portfolio	60,505	Q1 2025 New
OLMA Olema Pharmaceuticals, Inc.	$184M	$94,000 0.0% of portfolio	25,125	Q1 2025 Reduced 15.23%
AMLX Amylyx Pharmaceuticals, Inc.	$461M	$85,000 0.0% of portfolio	24,013	Q1 2025 New
LIFE A Tyr Pharma Inc	$53.2M	$84,000 0.0% of portfolio	45,451	Q1 2025 New
CRVS Corvus Pharmaceuticals, Inc.	$209M	$77,000 0.0% of portfolio	24,413	Q1 2025 New
RZLT Rezolute, Inc.	$209M	$69,000 0.0% of portfolio	24,123	Q1 2025 New
OVID Ovid Therapeutics Inc.	$47.9M	$66,000 0.0% of portfolio	215,060	Q1 2025 Added 46.0%
CMPX Compass Therapeutics, Inc.	$311M	$61,000 0.0% of portfolio	32,245	Q1 2025 New
IMMP Immutep LTD	$147M	$61,000 0.0% of portfolio	35,000	Q4 2024 Added 34.62%
PYXS Pyxis Oncology, Inc.	$40M	$37,000 0.0% of portfolio	38,260	Q1 2025 New
ALLO Allogene Therapeutics, Inc.	$204M	$34,000 0.0% of portfolio	23,766	Q1 2025 New
BMEA Biomea Fusion, Inc.	$53.3M	$30,000 0.0% of portfolio	14,117	Q1 2025 Reduced 85.16%
AIM Aim Immuno Tech Inc.	$426M	$19,000 0.0% of portfolio	162,000	Q1 2025 Reduced 5.26%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	27,681	Q1 2025 Added 79.3%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.